Table 1.
Comparison of definitions on early and intermediate hepatocellular carcinoma in current literatures.
Fig 1.
Comparison of survival between hepatocellular carcinoma (HCC) patients with single tumor ranging from 2–5cm or up to 3 tumors ≤ 3 cm (group A), single tumor > 5 cm (group SL), and multiple tumors > 3 cm (group B).
Group A patients had significantly better long-term survival than group SL and group B patients (p = 0.001 and p<0.001, respectively). The prognosis was similar between group SL and group B patients (p = 0.154).
Table 2.
Baseline demographics between HCC patients stratified by tumor number and size.
Fig 2.
Comparison of survival between solitary large (> 5 cm) hepatocellular carcinoma (HCC) patients receiving surgical resection (SR) or transarterial chemoembolization (TACE).
Solitary large HCC patients receiving SR had significantly better long-term survival than patients receiving TACE (p<0.001).
Table 3.
Baseline demographics in solitary large hepatocellular carcinoma patients receiving SR or TACE.
Fig 3.
Comparison of survival between solitary large (> 5 cm) hepatocellular carcinoma (HCC) patients receiving surgical resection (SR) or transarterial chemoembolization (TACE) in the propensity model.
Patients with solitary large HCC receiving SR had significantly better long-term survival than patients receiving TACE in the propensity model (p<0.001).
Table 4.
Baseline demographics in solitary large hepatocellular carcinoma patients receiving SR or TACE in the propensity model.
Table 5.
Univariate and multivariate survival analysis in solitary large hepatocellular carcinoma patients undergoing SR or TACE.